Tetra Bio-Pharma Confirms it is on Track to Receive Government Funding albuquerqueexpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from albuquerqueexpress.com Daily Mail and Mail on Sunday newspapers.
Tetra Provides Update on ARDS-003
Tetra Eyes Global Sepsis Market
OTTAWA, ON / ACCESSWIRE / December 21, 2020 /
Tetra Bio-Pharma Inc. ( Tetra or the Company ) (TSX:TBP)(OTCQB:TBPMF), a leader in cannabinoid-derived drug discovery and development, today announced that it expects government funding to help accelerate its sepsis and acute respiratory distress syndrome (ARDS) drug development.
As the first Endocannabinoid System (ECS) biotechnology company tackling sepsis, a life-threatening condition associated with COVID-19 and other inflammatory conditions including pneumonia and tumors, we were advised that we have been positively recommended for government funding of our drug candidate ARDS-003 for development as a therapeutic to treat sepsis and ARDS.